ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgaris Preclinical data show production of active, functional filaggrin delivered ...
・Azitra stated that its data showed positive outcomes as the company advances towards a first-in-human clinical trial of the skin disorder. ・The company noted that ichthyosis vulgaris impacts 1.3 ...
Ichthyosis is a condition that causes your skin to become dry, thick, itchy, red, or cracked. Its name comes from the Greek ...
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...
Ichthyosis is an inherited group of skin disorders characterized by xerosis and scaling. Other common phenotypic characteristics are hyperkeratosis, keratosis pilaris, palmar, and plantar ...
Ichthyosis features abnormal keratinization and resulting in scaling of the skin. Ichthyosis and pityriasis rubra pilaris are very difficult conditions for a child to deal with emotionally and ...
BRANFORD, Conn., Oct. 20, 2025 /PRNewswire/ -- Azitra, Inc. (AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...
The MarketWatch News Department was not involved in the creation of this content. ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback